372 related articles for article (PubMed ID: 28088573)
21. Heat shock protein antagonists in early stage clinical trials for NSCLC.
Hendriks LEL; Dingemans AC
Expert Opin Investig Drugs; 2017 May; 26(5):541-550. PubMed ID: 28274158
[TBL] [Abstract][Full Text] [Related]
22. The promise of heat shock protein inhibitors in the treatment of castration resistant prostate cancer.
Ischia J; Saad F; Gleave M
Curr Opin Urol; 2013 May; 23(3):194-200. PubMed ID: 23385973
[TBL] [Abstract][Full Text] [Related]
23. Heat shock proteins as emerging therapeutic targets.
Sõti C; Nagy E; Giricz Z; Vígh L; Csermely P; Ferdinandy P
Br J Pharmacol; 2005 Nov; 146(6):769-80. PubMed ID: 16170327
[TBL] [Abstract][Full Text] [Related]
24. Targeting hsp90 family members: A strategy to improve cancer cell death.
Buc Calderon P; Beck R; Glorieux C
Biochem Pharmacol; 2019 Jun; 164():177-187. PubMed ID: 30981878
[TBL] [Abstract][Full Text] [Related]
25. Heat shock proteins in cancer: targeting the 'chaperones'.
Nahleh Z; Tfayli A; Najm A; El Sayed A; Nahle Z
Future Med Chem; 2012 May; 4(7):927-35. PubMed ID: 22571616
[TBL] [Abstract][Full Text] [Related]
26. Heat shock protein 90: the cancer chaperone.
Neckers L
J Biosci; 2007 Apr; 32(3):517-30. PubMed ID: 17536171
[TBL] [Abstract][Full Text] [Related]
27. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
28. Heat-shock protein 90 inhibitors as antitumor agents: a survey of the literature from 2005 to 2010.
Messaoudi S; Peyrat JF; Brion JD; Alami M
Expert Opin Ther Pat; 2011 Oct; 21(10):1501-42. PubMed ID: 21689065
[TBL] [Abstract][Full Text] [Related]
29. Targeted delivery of HSP90 inhibitors for efficient therapy of CD44-positive acute myeloid leukemia and solid tumor-colon cancer.
Jia L; Yang H; Liu Y; Zhou Y; Li G; Zhou Q; Xu Y; Huang Z; Ye F; Ye J; Liu A; Ji C
J Nanobiotechnology; 2024 Apr; 22(1):198. PubMed ID: 38649957
[TBL] [Abstract][Full Text] [Related]
30. Emerging Roles of Extracellular Hsp90 in Cancer.
Wong DS; Jay DG
Adv Cancer Res; 2016; 129():141-63. PubMed ID: 26916004
[TBL] [Abstract][Full Text] [Related]
31. Selective Inhibition of the Hsp90α Isoform.
Mishra SJ; Khandelwal A; Banerjee M; Balch M; Peng S; Davis RE; Merfeld T; Munthali V; Deng J; Matts RL; Blagg BSJ
Angew Chem Int Ed Engl; 2021 May; 60(19):10547-10551. PubMed ID: 33621416
[TBL] [Abstract][Full Text] [Related]
32. Heat shock protein 90 inhibitors as therapeutic agents.
Gomez-Monterrey I; Sala M; Musella S; Campiglia P
Recent Pat Anticancer Drug Discov; 2012 Sep; 7(3):313-36. PubMed ID: 22338602
[TBL] [Abstract][Full Text] [Related]
33. Targeting Heat-Shock Protein 90 (HSP90) as a Complementary Strategy to Immune Checkpoint Blockade for Cancer Therapy.
Proia DA; Kaufmann GF
Cancer Immunol Res; 2015 Jun; 3(6):583-9. PubMed ID: 25948551
[TBL] [Abstract][Full Text] [Related]
34. Old and New Approaches to Target the Hsp90 Chaperone.
Sanchez J; Carter TR; Cohen MS; Blagg BSJ
Curr Cancer Drug Targets; 2020; 20(4):253-270. PubMed ID: 31793427
[TBL] [Abstract][Full Text] [Related]
35. HSP90 inhibitors: current development and potential in cancer therapy.
Sidera K; Patsavoudi E
Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):1-20. PubMed ID: 23312026
[TBL] [Abstract][Full Text] [Related]
36. Targeting chaperones in transformed systems--a focus on Hsp90 and cancer.
Chiosis G
Expert Opin Ther Targets; 2006 Feb; 10(1):37-50. PubMed ID: 16441227
[TBL] [Abstract][Full Text] [Related]
37. The Right Tool for the Job: An Overview of Hsp90 Inhibitors.
Koren J; Blagg BSJ
Adv Exp Med Biol; 2020; 1243():135-146. PubMed ID: 32297216
[TBL] [Abstract][Full Text] [Related]
38. [Heat shock proteins: new target in cytoprotective and tumor therapy].
Bao XQ; Liu GT
Yao Xue Xue Bao; 2008 Mar; 43(3):234-40. PubMed ID: 18630257
[TBL] [Abstract][Full Text] [Related]
39. Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective.
Kumalo HM; Bhakat S; Soliman ME
Chem Biol Drug Des; 2015 Nov; 86(5):1131-60. PubMed ID: 25958815
[TBL] [Abstract][Full Text] [Related]
40. Nanoparticle approaches to combating drug resistance.
Moon JH; Moxley JW; Zhang P; Cui H
Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]